GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hester Biosciences Ltd (BOM:524669) » Definitions » Short-Term Capital Lease Obligation

Hester Biosciences (BOM:524669) Short-Term Capital Lease Obligation : ₹0 Mil (As of Mar. 2025)


View and export this data going back to 1994. Start your Free Trial

What is Hester Biosciences Short-Term Capital Lease Obligation?

Hester Biosciences's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2025 was ₹0 Mil.

Hester Biosciences's annual Short-Term Capital Lease Obligation declined from Mar. 2023 (₹5 Mil) to Mar. 2024 (₹0 Mil) and declined from Mar. 2024 (₹0 Mil) to Mar. 2025 (₹0 Mil).

Hester Biosciences Short-Term Capital Lease Obligation Historical Data

The historical data trend for Hester Biosciences's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hester Biosciences Short-Term Capital Lease Obligation Chart

Hester Biosciences Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Short-Term Capital Lease Obligation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.24 4.44 5.00 0.42 -

Hester Biosciences Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Short-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.42 - - - -

Hester Biosciences Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Hester Biosciences Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Hester Biosciences's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Hester Biosciences Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hester Biosciences Ltd (BOM:524669) » Definitions » Short-Term Capital Lease Obligation
Comparable Companies
BOM:507789 BOM:543389 BOM:506197 NSE:BETA BOM:530199 BOM:539872 BOM:524470 BOM:543329 BOM:531633 BOM:506260 ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
HESTERBIO:India
Address
Motilal Hirabhai Road, Pushpak, 1st Floor, Panchvati Circle, Ahmedabad, GJ, IND, 380006
Website
https://www.hester.in
Hester Biosciences Ltd is an India based animal healthcare company. The company's operating segment includes Poultry Healthcare, Animal Healthcare, Petcare and Others. It generates maximum revenue from the Poultry Healthcare segment. The company's products are used to cure poultry diseases such as Fowl Pox, Newcastle Disease, Infectious Bronchitis and others. Geographically, it sells the products in India and also exports them to other countries, of which key revenue is derived from India.

Hester Biosciences Headlines

No Headlines